Oral PCSK9 inhibitor Significantly Reduces LDL-C in Hypercholesterolemia HCP Live, 31 May 2024 Sharon Barr, PhD Credit: LinkedIn Positive data from a Phase 1 trial suggested the benefit of AZD0780, an oral small molecule…